Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS
- Status
- UNKNOWN
- Phase
- PHASE2
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- Status
- SUSPENDED
- Phase
- PHASE1
Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Autologous Transplant Targeted Against Crohn's
- Status
- WITHDRAWN
- Phase
- PHASE2
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML
- Status
- COMPLETED
- Phase
- PHASE2
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
- Status
- TERMINATED
- Phase
- PHASE2